Brookfield Asset Management - CENTESSA PHARMACEUTICALS PLC ownership

CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 48 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 4.0%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of CENTESSA PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2021$447,000
+9.3%
26,788
+45.6%
0.00%0.0%
Q2 2021$409,00018,4040.00%
Other shareholders
CENTESSA PHARMACEUTICALS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 17,923,892$299,329,00065.12%
Vida Ventures Advisors, LLC 3,931,818$65,661,00018.81%
Samsara BioCapital, LLC 1,537,533$25,677,0004.03%
VR Adviser, LLC 1,127,272$18,825,0002.42%
Logos Global Management LP 1,069,545$17,861,0001.29%
Cormorant Asset Management, LP 1,727,273$28,724,0001.17%
GENERAL ATLANTIC, L.P. 9,681,818$161,686,0000.95%
Affinity Asset Advisors, LLC 203,183$3,393,0000.86%
RA Capital Management 3,577,094$59,737,0000.83%
Boxer Capital, LLC 1,334,227$22,282,0000.78%
View complete list of CENTESSA PHARMACEUTICALS PLC shareholders